- Citations, last 5 years
- 5 075
- Works, last 5 years
- 342
- h-index
- 305
- Scientists listed
- 50
- Grants since 2016
- 113
Grants received
2018–2028 · contract · N01
Task V29: STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID
Thomas Hassel · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2018 · contract · N01
Feasibility Assessment of HIV Env Protein Antigens
Antu Dey · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2019 · contract · N01
NIAID Process Development and Analytical Support for Development of HIV Vaccines
Thomas Hassell · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2018 · contract · N01
Product Development Plans to Support HIV Vaccine Manufacturing Efforts
Antu Dey · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2018 · contract · N01
PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS
Antu Dey · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2019 · research · Global Health
International AIDS Vaccine Initiative Inc - to develop on behalf of the Global Health Clinical Consortium a training program for study coordinators working on clinical trials addressing major...
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2017–2018 · contract · N01
COORDINATION AND TECHNICAL SUPPORT
Thomas Hassell · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2020 · cooperative agreement · U01
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa
Ann M Ginsberg · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2018 · research · Global Health
International AIDS Vaccine Initiative Inc - to provide general operating support for HIV vaccine research and product development capacity at IAVI’s Design and Development Laboratory
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2017–2023 · cooperative agreement · U01
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa
Dagna Laufer · International AIDS Vaccine Initiative · funded by National Institutes of Health
2017–2018 · contract · N01
Product Development Plans to Support HIV Vaccine Manufacturing Efforts
Antu Dey · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2021 · program · P01
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
Christopher Parks · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2018 · contract · N01
IGF::OT::IGF PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS
Antu Dey · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2020 · research · Global Health
International AIDS Vaccine Initiative - to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2016–2021 · program · P01
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
Christopher Parks · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2024 · research · Global Health
International AIDS Vaccine Initiative - to advance the CAVD-supported projects through the translational stage and into clinical evaluation, ultimately resulting in successful new HIV/AID...
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2016–2017 · contract · N01
IGF::OT::IGF ANALYSIS OF HIV-1 ENV HOST CELL PROTEINS BY MASS SPECTROMETRY METHOD
Antu Dey · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2021 · program · P01
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
Christopher Parks · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2018 · research · Global Health
International AIDS Vaccine Initiative Inc - to advance development and conduct a phase 1 clinical trial with VSV G-Env.BG505, a new HIV Env vaccine based on a novel live chimeric virus
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2016–2018 · research · Global Health
International AIDS Vaccine Initiative Inc - to facilitate communications and interactions among the parties composing the CAVD, in the belief that collaborative approaches will accelerate the...
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2016–2022 · program · P01
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
Christopher Parks · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2021 · program · P01
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
Christopher Parks · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF COORDINATION AND TECHNICAL SUPPORT
Thomas Hassell · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2029 · research · Global Health
International AIDS Vaccine Initiative - to support the preparation of clinical materials, execution of toxicology studies and data analyses for CAVD investigators towards development of a...
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2016–2018 · research · Global Health
International AIDS Vaccine Initiative Inc - to support an independent preclinical efficacy study and continued analysis of a promising experimental HIV vaccine with significant potential to a...
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation
2016–2022 · program · P01
Gene Expression Analysis Core
John D. Aitchison · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2022 · program · P01
Env-Specific B Cell Repertoire Responses to NFL Trimer vaccines
Jiang Zhu · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2022 · program · P01
Design of subtype C NFL trimers for virus-like particle array
Richard Thomas Wyatt · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2022 · program · P01
Administrative Core
Beth Rasmussen · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2022 · program · P01
In vivo testing of novel HIV Env vaccine platforms to advance preclinical HIV vaccine development
Gavin Morrow · International AIDS Vaccine Initiative · funded by National Institutes of Health
2016–2022 · program · P01
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies
Christopher Parks · International AIDS Vaccine Initiative · funded by National Institutes of Health
2014–2020 · contract · N01
STAGED VACCINE DEVELOPMENT: IMMUNOPROPHYLAXIS BY GENE TRANSFER
Thomas Hassell · International AIDS Vaccine Initiative · funded by National Institutes of Health
2013–2020 · research · Global Health
International AIDS Vaccine Initiative - to demonstrate that an HIV ENV based immunogen(s) can be designed to elicit bnAbs in humans and has the potential to prevent HIV infection.
International AIDS Vaccine Initiative · funded by Bill and Melinda Gates Foundation